JP2008074862A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008074862A5 JP2008074862A5 JP2007279663A JP2007279663A JP2008074862A5 JP 2008074862 A5 JP2008074862 A5 JP 2008074862A5 JP 2007279663 A JP2007279663 A JP 2007279663A JP 2007279663 A JP2007279663 A JP 2007279663A JP 2008074862 A5 JP2008074862 A5 JP 2008074862A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- aryl
- group
- cycloalkyl
- heteroaryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 0 C*C(C(*)N(CC1)C(*)(CC2)CCN2C(*)=O)C1(C)C(*)(*)*(CC1)CC*1I Chemical compound C*C(C(*)N(CC1)C(*)(CC2)CCN2C(*)=O)C1(C)C(*)(*)*(CC1)CC*1I 0.000 description 5
- PKTGNMWRUISHQR-AEGJEPNBSA-N CC(CN(CC1)C(C)(CC2)CCN2C(c2c(C)ncnc2C)O)N1[C@H](C(CC1)CCN1S(C1CC1)(=O)=O)c1cccc(F)c1 Chemical compound CC(CN(CC1)C(C)(CC2)CCN2C(c2c(C)ncnc2C)O)N1[C@H](C(CC1)CCN1S(C1CC1)(=O)=O)c1cccc(F)c1 PKTGNMWRUISHQR-AEGJEPNBSA-N 0.000 description 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27993801P | 2001-03-29 | 2001-03-29 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002577819A Division JP4248251B2 (ja) | 2001-03-29 | 2002-03-27 | Ａｉｄｓの処置に有用なｃｃｒ５アンタゴニスト |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008074862A JP2008074862A (ja) | 2008-04-03 |
| JP2008074862A5 true JP2008074862A5 (https=) | 2009-01-15 |
Family
ID=23070981
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002577819A Expired - Fee Related JP4248251B2 (ja) | 2001-03-29 | 2002-03-27 | Ａｉｄｓの処置に有用なｃｃｒ５アンタゴニスト |
| JP2007279663A Withdrawn JP2008074862A (ja) | 2001-03-29 | 2007-10-26 | Ａｉｄｓの処置に有用なｃｃｒ５アンタゴニスト |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002577819A Expired - Fee Related JP4248251B2 (ja) | 2001-03-29 | 2002-03-27 | Ａｉｄｓの処置に有用なｃｃｒ５アンタゴニスト |
Country Status (29)
| Country | Link |
|---|---|
| US (5) | US6720325B2 (https=) |
| EP (2) | EP1373256B1 (https=) |
| JP (2) | JP4248251B2 (https=) |
| KR (1) | KR100613528B1 (https=) |
| CN (1) | CN100519554C (https=) |
| AR (1) | AR033452A1 (https=) |
| AT (2) | ATE299139T1 (https=) |
| AU (1) | AU2002255947B8 (https=) |
| BR (1) | BR0208398A (https=) |
| CA (1) | CA2442227C (https=) |
| CZ (1) | CZ20032636A3 (https=) |
| DE (2) | DE60204951T2 (https=) |
| DK (1) | DK1373256T3 (https=) |
| ES (2) | ES2242856T3 (https=) |
| HU (1) | HUP0400349A3 (https=) |
| IL (1) | IL157551A0 (https=) |
| MX (1) | MXPA03008853A (https=) |
| MY (1) | MY128609A (https=) |
| NO (1) | NO326349B1 (https=) |
| NZ (1) | NZ527768A (https=) |
| PE (1) | PE20020996A1 (https=) |
| PL (1) | PL364560A1 (https=) |
| PT (1) | PT1373256E (https=) |
| RU (1) | RU2316553C2 (https=) |
| SI (1) | SI1373256T1 (https=) |
| SK (1) | SK287521B6 (https=) |
| TW (1) | TWI237638B (https=) |
| WO (1) | WO2002079194A1 (https=) |
| ZA (1) | ZA200307474B (https=) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR033452A1 (es) * | 2001-03-29 | 2003-12-17 | Schering Corp | Antagonistas de ccr5 utiles para el tratamiento del sida |
| ATE319703T1 (de) | 2001-07-02 | 2006-03-15 | Piperidinverbindungen, die sich als modulatoren der chemokinrezeptoraktivität eignen | |
| SE0200843D0 (sv) | 2002-03-19 | 2002-03-19 | Astrazeneca Ab | Chemical compounds |
| SE0200844D0 (sv) | 2002-03-19 | 2002-03-19 | Astrazeneca Ab | Chemical compounds |
| TW200504033A (en) | 2002-10-23 | 2005-02-01 | Procter & Gamble | Melanocortin receptor ligands |
| AU2003300911A1 (en) * | 2002-12-13 | 2004-07-09 | Smithkline Beecham Corporation | Heterocyclic compounds as ccr5 antagonists |
| PE20040769A1 (es) * | 2002-12-18 | 2004-11-06 | Schering Corp | Derivados de piperidina utiles como antagonisas ccr5 |
| SE0300957D0 (sv) | 2003-04-01 | 2003-04-01 | Astrazeneca Ab | Chemical compounds |
| KR20060100409A (ko) * | 2003-11-03 | 2006-09-20 | 쉐링 코포레이션 | 케모킨 수용체 억제제로서 유용한 비피페리디닐 유도체 |
| CA2554465A1 (en) * | 2004-02-05 | 2005-08-25 | Schering Corporation | Piperidine derivatives useful as ccr3 antagonists |
| SE0400925D0 (sv) * | 2004-04-06 | 2004-04-06 | Astrazeneca Ab | Chemical compounds |
| EA015517B1 (ru) * | 2004-04-13 | 2011-08-30 | Инсайт Корпорейшн | Производные пиперазинилпиперидина в качестве антагонистов хемокинового рецептора |
| US8143404B2 (en) * | 2004-09-13 | 2012-03-27 | Ono Pharmaceutical Co., Ltd | Nitrogenous heterocylic derivative and medicine containing the same as an active ingredient |
| WO2006071958A1 (en) | 2004-12-29 | 2006-07-06 | Millennium Pharmaceuticals, Inc. | Compounds useful as chemokine receptor antagonists |
| WO2006071875A1 (en) * | 2004-12-29 | 2006-07-06 | Millennium Pharmaceuticals, Inc. | Compounds useful as chemokine receptor antagonists |
| SG158861A1 (en) * | 2005-01-06 | 2010-02-26 | Schering Corp | Synthesis of ccr5 receptor antagonists |
| JP2008526862A (ja) * | 2005-01-06 | 2008-07-24 | シェーリング コーポレイション | ピペラジン化合物の薬学的な塩の調製 |
| JP4822367B2 (ja) * | 2005-02-23 | 2011-11-24 | シェーリング コーポレイション | ケモカイン受容体のインヒビターとして有用なピペリジニルピペリジン誘導体 |
| EP1858887A1 (en) * | 2005-02-23 | 2007-11-28 | Schering Corporation | Piperidinyl piperazine derivatives useful as inhibitors of chemokine receptors |
| JP2009501793A (ja) | 2005-07-21 | 2009-01-22 | アストラゼネカ・アクチエボラーグ | 新規ピペリジン誘導体 |
| US7462485B2 (en) * | 2005-10-07 | 2008-12-09 | Glaser Lawrence F | Modified erythrocytes and uses thereof |
| TW200745087A (en) * | 2006-02-24 | 2007-12-16 | Schering Corp | CCR5 antagonists useful for treating HIV |
| WO2008030853A2 (en) * | 2006-09-06 | 2008-03-13 | Incyte Corporation | Combination therapy for human immunodeficiency virus infection |
| CA2673233A1 (en) * | 2006-12-22 | 2008-07-03 | Schering Corporation | Process for preparing ccr-5 receptor antagonists utilizing 4-substituted 1-cyclopropane-sulfonyl-piperidinyl compounds |
| CA2716838C (en) * | 2008-02-29 | 2014-01-07 | Schering Corporation | Ccr5 antagonists as prophylactics for preventing hiv infection and methods of inhibiting transmission of same |
| US11629196B2 (en) | 2020-04-27 | 2023-04-18 | Incelldx, Inc. | Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5368854A (en) | 1992-08-20 | 1994-11-29 | Schering Corporation | Use of IL-10 to treat inflammatory bowel disease |
| WO1994018192A1 (en) | 1993-02-12 | 1994-08-18 | Merck & Co., Inc. | Piperazine derivatives as hiv protease inhibitors |
| IL117149A0 (en) | 1995-02-23 | 1996-06-18 | Schering Corp | Muscarinic antagonists |
| US5889006A (en) | 1995-02-23 | 1999-03-30 | Schering Corporation | Muscarinic antagonists |
| EP1103276B1 (en) | 1995-06-07 | 2003-09-10 | Kimberly-Clark Worldwide, Inc. | Inhibition of exoprotein in absorbent article |
| NZ321575A (en) | 1995-10-30 | 1999-05-28 | Janssen Pharmaceutica Nv | 1-(1,2-disubstituted piperidinyl)-4- substituted piperazine derivatives |
| TW531537B (en) | 1995-12-27 | 2003-05-11 | Janssen Pharmaceutica Nv | 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives |
| US5952349A (en) | 1996-07-10 | 1999-09-14 | Schering Corporation | Muscarinic antagonists for treating memory loss |
| US5977138A (en) | 1996-08-15 | 1999-11-02 | Schering Corporation | Ether muscarinic antagonists |
| CA2296314A1 (en) | 1997-07-25 | 1999-02-04 | Merck & Co., Inc. | Cyclic amine modulators of chemokine receptor activity |
| US6066636A (en) | 1998-06-30 | 2000-05-23 | Schering Corporation | Muscarinic antagonists |
| EP1013276A1 (en) * | 1998-12-23 | 2000-06-28 | Pfizer Inc. | Aminoazacycloalkanes as CCR5 modulators |
| KR100439357B1 (ko) * | 1999-05-04 | 2004-07-07 | 쉐링 코포레이션 | Ｃｃｒ５ 길항제로서 유용한 피페리딘 유도체 |
| SK287418B6 (sk) | 1999-05-04 | 2010-09-07 | Schering Corporation | Farmaceutický prípravok s obsahom CCR5 antagonistov a súprava s obsahom tohto prípravku |
| AR033452A1 (es) * | 2001-03-29 | 2003-12-17 | Schering Corp | Antagonistas de ccr5 utiles para el tratamiento del sida |
-
2002
- 2002-03-27 AR ARP020101142A patent/AR033452A1/es unknown
- 2002-03-27 JP JP2002577819A patent/JP4248251B2/ja not_active Expired - Fee Related
- 2002-03-27 AU AU2002255947A patent/AU2002255947B8/en not_active Ceased
- 2002-03-27 SK SK1196-2003A patent/SK287521B6/sk not_active IP Right Cessation
- 2002-03-27 RU RU2003131879/04A patent/RU2316553C2/ru not_active IP Right Cessation
- 2002-03-27 HU HU0400349A patent/HUP0400349A3/hu unknown
- 2002-03-27 AT AT02725381T patent/ATE299139T1/de active
- 2002-03-27 ES ES02725381T patent/ES2242856T3/es not_active Expired - Lifetime
- 2002-03-27 EP EP02725381A patent/EP1373256B1/en not_active Expired - Lifetime
- 2002-03-27 CA CA002442227A patent/CA2442227C/en not_active Expired - Fee Related
- 2002-03-27 IL IL15755102A patent/IL157551A0/xx not_active IP Right Cessation
- 2002-03-27 NZ NZ527768A patent/NZ527768A/en unknown
- 2002-03-27 MX MXPA03008853A patent/MXPA03008853A/es active IP Right Grant
- 2002-03-27 WO PCT/US2002/009491 patent/WO2002079194A1/en not_active Ceased
- 2002-03-27 AT AT05009882T patent/ATE466009T1/de not_active IP Right Cessation
- 2002-03-27 EP EP05009882A patent/EP1591444B1/en not_active Expired - Lifetime
- 2002-03-27 SI SI200230169T patent/SI1373256T1/sl unknown
- 2002-03-27 KR KR1020037012565A patent/KR100613528B1/ko not_active Expired - Fee Related
- 2002-03-27 US US10/107,940 patent/US6720325B2/en not_active Expired - Lifetime
- 2002-03-27 CZ CZ20032636A patent/CZ20032636A3/cs unknown
- 2002-03-27 PL PL02364560A patent/PL364560A1/xx not_active IP Right Cessation
- 2002-03-27 BR BR0208398-1A patent/BR0208398A/pt not_active IP Right Cessation
- 2002-03-27 PT PT02725381T patent/PT1373256E/pt unknown
- 2002-03-27 CN CNB028076540A patent/CN100519554C/zh not_active Expired - Fee Related
- 2002-03-27 ES ES05009882T patent/ES2342942T3/es not_active Expired - Lifetime
- 2002-03-27 DE DE60204951T patent/DE60204951T2/de not_active Expired - Lifetime
- 2002-03-27 DE DE60236218T patent/DE60236218D1/de not_active Expired - Lifetime
- 2002-03-27 PE PE2002000251A patent/PE20020996A1/es not_active Application Discontinuation
- 2002-03-27 DK DK02725381T patent/DK1373256T3/da active
- 2002-03-28 TW TW091106166A patent/TWI237638B/zh active
- 2002-03-28 MY MYPI20021140A patent/MY128609A/en unknown
-
2003
- 2003-09-25 ZA ZA200307474A patent/ZA200307474B/en unknown
- 2003-09-26 NO NO20034311A patent/NO326349B1/no not_active IP Right Cessation
-
2004
- 2004-02-06 US US10/773,521 patent/US6900211B2/en not_active Expired - Fee Related
- 2004-10-21 US US10/970,216 patent/US7008946B2/en not_active Expired - Fee Related
-
2005
- 2005-02-17 US US11/059,785 patent/US7060701B2/en not_active Expired - Fee Related
- 2005-10-14 US US11/250,247 patent/US7098213B2/en not_active Expired - Fee Related
-
2007
- 2007-10-26 JP JP2007279663A patent/JP2008074862A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008074862A5 (https=) | ||
| DE60021370C5 (de) | Piperazinderivate verwendbar als ccr5 antagonisten | |
| RU2001132632A (ru) | Производные пиперазина, применимые в качестве антагонистов CCR5 | |
| JP2009519218A5 (https=) | ||
| JP2007501859A5 (https=) | ||
| JP2022507527A5 (https=) | ||
| JP2009534404A5 (https=) | ||
| JP2008525417A5 (https=) | ||
| JP2006501292A5 (https=) | ||
| JP2009545611A5 (https=) | ||
| JP2011511073A5 (https=) | ||
| JP2014530240A5 (https=) | ||
| JP2006523193A5 (https=) | ||
| JP2004516314A5 (https=) | ||
| JP2001526269A5 (https=) | ||
| JP2012021003A5 (https=) | ||
| JP2013523803A5 (https=) | ||
| JP2015504067A5 (https=) | ||
| JP2013523802A5 (https=) | ||
| JP2007523151A5 (https=) | ||
| JP2004517860A5 (https=) | ||
| JP2013542218A5 (https=) | ||
| JP2007534702A5 (https=) | ||
| JP2010514786A5 (https=) | ||
| JP2006527170A5 (https=) |